Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GenPHSats in Limb Girdle Muscular Dystrophies
NCT05588401Phase 2Unknown
- Start
- Jul 2024
- Primary completion
- Jul 2025
01
Overview
Phase 2, open-label, single-arm trial in limb-girdle muscular dystrophy (LGMD). Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 1 year. Status: unknown.
02
Conditions
limb-girdle muscular dystrophy (LGMD)
Beyond the preview
Go deeper on NCT05588401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05588401.